| ADHD is significantly underdiagnosed in women, many of whom are not identified until adulthood, often around age 36 to 38, largely due to gender biased symptom recognition and limited awareness of how hormonal changes across the female lifespan impact the condition. Estrogen plays a central role in regulating dopamine and serotonin, making women particularly vulnerable to symptom fluctuations during puberty, menstruation, postpartum, and perimenopause. Declining estrogen can worsen inattention, impulsivity, and emotional instability through reduced dopamine availability. |
| Growing research also points to the gut brain axis as a factor in ADHD, with gut microbiota influencing neurotransmitter production and brain function. Dysbiosis has been linked to greater symptom severity, driving interest in integrative approaches such as probiotics, dietary interventions, and microbiome focused care. With diagnoses among adult women rising sharply, primary care providers are well positioned to close the recognition gap. This presentation equips clinicians with practical, evidence based tools integrating hormonal, neurochemical, and gut health perspectives to support more accurate diagnoses and individualized care. |
References to webinars are from our accredited laboratory network. Health care providers are encouraged to explore the original source material and apply their clinical expertise when interpreting this information.